March 2015 Evaluation Summaries - Baptist Health South Florida · CME Conference Evaluation Summaries March 2015 FINAL SCORE 2/19 13th Annual International Cardiovascular Disease

Continuing Medical Education Department CME Conference Evaluation Summaries

March 2015

FINAL SCORE

2/19 13th Annual International Cardiovascular Disease Prevention Symposium

4.7

2/28 Seventh Annual Mental and Behavioral Health Symposium 4.6

3/5 Cardiovascular Conference Series: Advances in Antithrombotic Therapy: Update on NOACs 4.9

3/10 An Overview of the Art of Intentional Communication: The Role of the Physician in The Patient Experience

4.9

3/10 Pediatric Emergency Conference: Delayed Diagnosis in Pediatric Acute Care- Avoid Legal Issues

5.0

3/12 OB/GYN Conference Series: Infectious Diseases 5.0

CONTINUING MEDICAL EDUCATION DEPARTMENT 13th Annual Cardiovascular Disease Prevention International Symposium

February 19-22, 2015

Combined Overall Evaluation Summary

Physicians Attended: 420

Physicians Responded: 165

Scoring Key: 5 - Excellent 4 - Very Good 3 - Good 2 - Fair 1 - Poor

1. Overall impression of symposium. 4.8

2. Meeting Facilities.

• Location 4.6

• Symposium Registration 4.9

• Meeting Room 4.7

Total Average 4.8

How did you hear about this meeting?

(43%) BH website (53)

(28%) Past Attendee (46)

(21%) Search for CVDP (35)

(16%) Mail (27)

(14%) Email (23)

(11%) Colleague (18)

(7%) Search for Fl. Medical Symposium (11)

(2%) LinkedIn (3)

(1%) Journal (2)

(1%) Twitter (2)

(11%) Other (18)

• PBCMS

• Dr. Fridman

• Brochure

• Spouse

• Friend

• Co-worker

(27%) No Answer (45)

Yes No No Answer

Have you attended this symposium in the past? (96) 58% (70) 42% (0) 0%

Would you attend this symposium again next year?

• Attend every other year (3)

• Information not always clinically relevant or new enough to

attend every year.

• Location and subject matter.

• Very current.

(151) 92%

(12) 7%

(3) 2%

Would you recommend this symposium to a colleague? (165) 100%

(0) 0% (0) 0%

How many patients will you see in your practice next week that will likely be impacted by what you learned at

this symposium?

16 1-5(10%) 22 6-10 (13%) 82 Over 10 (50%) 33 Not Applicable (20%) 13 No Answer(8%)

1) Which best describes you?

2) How many people accompanied you?

How many Other Adults? 95 How many Children? 24

3) What activities are planned during your visit? (Check all that apply.)

If staying at a hotel:

4) Where are you staying during your visit to Miami/Miami Beach?

Please list hotel if not the Fontainebleau:

Courtyard Marriot

Eden Roc

La Quinta Inn

Rodeway Inn

If staying at a hotel:

5) How many hotel rooms did you reserve?

Is this your first visit to Florida? 4 Yes 70 No 92 No Answer

Is this your first visit to Miami Beach? 19 Yes 54 No 93 No Answer

I traveled to Florida, and I

am staying at the

Fontainebleau or a nearby

hotel.

I live in Florida (farther

than 50 miles away), and

I am staying at the

Fontainebleau or a

nearby hotel.

I live in South Florida

(within 50 mile radius),

and I am staying at the

Fontainebleau or a

nearby hotel.

I live in South Florida,

and I am driving

(being driven) to this

meeting.

54 (33%) 9 (5%) 5 (3%) 91 (55%)

None Other Adults (age 18 or older) Children (age 0-17)

78 (47%) 85 (52%) 19 (12%)

Medical Symposium

only

Vacation activities for

self/family

Shopping Site-seeing Travel to other

Florida cities

115 (70%) 40 (24%) 19 (12%) 18 (11%) 6 (4%)

The Fontainebleau Hotel Another hotel on Miami

Beach

Another hotel not on

Miami Beach

Other Location

59 (36%) 5 33%) 4 (2%) 12 (7%)

One room Two rooms Three rooms More then 3 rooms

59 (36%) 3 (4%) 0 0

If visiting Florida, what is your home city, state, country?

Other states 124 NY 22 OH 11 NJ 10 PA 7 CA 6 MN 6 NC 6 GA 5 IL 5 IN 5 VA 5 WI 4 MD 3 CO 2 KY 2 LA 2 MA 2 MI 2 MO 2 MS 2 TN 2 TX 2 AZ 1 CT 1 DC 1 ID 1 KS 1 NE 1 NV 1 RI 1 SC 1 VT 1 WA 1

International 61 Canada 27

Italy 18 Cayman Islands 3

Brazil 2 China 1 France 1

Jamaica 1 Korea 1

Lithuania 1 Nigeria 1

Puerto Rico 1 Saudi Arabia 1

Spain 1 Sweden 1 Turkey 1

1. What do you intend to do differently in the treatment of your patients as a result of what you learned at this

symposium? What new strategies will you apply in your practice of patient care?

• Encourage lifestyle changes. (12)

• Risk stratification. (8)

• Patient education. (7)

• Order more Apo-B testing. (5)

• More emphasis on reducing sitting and mindfulness. (4)

• Educate about the importance of healthy living. (4)

• Consider additional laboratory testing to better diagnose and treat my patients and to consider

other non-statin therapies. (3)

• CVD prevention. (3)

• Mediterranean diet lifestyle. (3)

• Track inflammation. (2)

• How to talk to obese patients and address weight lose. (2)

• Re-evaluate statin use. (2)

• Increase calcium scoring scanning. (2)

• Share this information with colleagues.

• Order more sleep studies.

• More primary prevention education.

• No HRT to prevent CVD in women.

• Screen for sleep apnea and more.

• More lively discussions with patients.

• Look closer at medications and optimize treatment.

• Emphasize the importance of combining exercise, diet and mindfulness.

• New and upcoming recommendations from the research presented on sodium, obesity and

saturated fats.

• Potentially use ApoB as a marker to determine treatment initiation in some populations.

• Recommend Mediterranean diet.

• Consider further testing for lipids.

• I plan to impart in those who have symptoms of stroke/diabetes/weight problems.

• Readdress family history, labs and information given.

• Assessment of ASA resistance.

• Look more at elevations of CRP when normal PLA2.

• Refine dietary intake.

• Continue to track emerging studies.

• Educating patients of risk factors and healthy lifestyle/

• Continue to practice wellness and prevention.

• Yogurt can be very beneficial.

• Low saturated fat diet.

• Do more individualized testing and treatment.

• Cholesterol treatment strategies.

• Nutrition strategies.

• Use Reynolds Risk Score.

• Screen more patients for obstructive sleep apnea (OSA).

• How to interpret guidelines and recommendations.

• Absolute risk reduction should be mandatory for all studies. Too many statistical manipulations with

relative risk.

• Better use of advanced lipid testing.

• Risk factors in women.

• Will screen more thoroughly for peripheral artery disease (PAD).

• Weight loss approach.

• Start a blog.

• More aggressive treatment of at risk patients with statins.

• Better exercise prescription.

• Test for sterol absorption.

• Put more emphasis on non-HDL cholesterol results.

• New approach to primary and secondary prevention.

• Role of weight loss medications in risk and disease management.

• Improve prevention and treatment of diseases.

2. If you do not plan to implement any new strategies learned at this symposium, please list any barriers or

obstacles that might keep you from doing so.

• Patient compliance. (2)

• Cost. (2)

• Insurance coverage is the main barrier to testing.

• Advanced age of patient population.

• Lifestyles.

• Time.

• Current guidelines don’t recommend ApoB LDL particles because of cost of labs.

3. Suggested topics and/or speakers you would like for future symposiums related to Cardiovascular Disease

Prevention.

• Comparison of oils. (2)

• Recommend a behavioral medicine psychologist that specializes in CVDP to discuss the role of

psychology in treatment and prevention. (2)

• A dietitian can help supplement the information given. (2)

• Physiological benefits/ affects of exercise in various forms. (2)

• More women and heart disease topics. (2)

• COPD and ventilators.

• Include more children health topics.

• Talk about more natural ways of preventing cardiac disease aside from conservative ways.

• Heart failure topics.

• Sleep apnea and hypertension and CVD.

• More research on exercise.

• Stress reduction.

• Pulmonary and cardiac rehabilitation related topics.

• Exercise physiologist and their role in maintain patients’ health in cardiac rehabilitation.

• More debate about the benefits of calcium scoring.

• Reports ion studies on diet, exercise, healthy lifestyle therapies and their effects on all aspects of

CVD.

• Focus on Hispanic population, as there is a growing number in the United States and where I live in

Connecticut.

• Congestive heart failure (CHF) diagnosis, treatment and management and the psychological

impact.

• Hypertension management.

• Atrial fibrillation (AFib).

• Reducing CHF.

• Cardiovascular rehabilitation.

• The effects of caffeine on the cardiovascular system.

• Comparison of Omega 6 versus Omega 3.

• Pancreatic cancer and chronic pancreatitis.

• More discussion on Ecigarettes and whether they are harmful or helpful.

• Continue with lifestyle interventions such as nutrition, meditation, yoga and spirituality.

• Updates on new medicines.

• Stress associated with cardiovascular disease.

• Calcium and Vitamin D.

• Non-compliance with medication and how to get patients to comply.

• More preventive interventions versus path physiological.

• VTE/PE risks, management and prevention.

• Congestive heart failure (CHF) related topics.

• New developments.

• Continue the debate on imaging lipid markers and biomarkers for identification of the at risk

patients and monitoring therapy.

• Continue to discuss residual risk.

• Need practical talks regarding exercise.

• Address stress management.

• Ralph Defronzo on insulin resistance.

• Heart-brain relations.

• Common drugs and their toxicity on the cardiovascular system.

• Bring in an expert on smoking cessation.

• Testing and evaluation for CAD for primary prevention in the out patient setting.

• More practical aspects.

• Controversy is the best approach to addressing topics. Need to add a speaker regarding evidence

to use alternative supplements and how to choose the appropriate patient.

• The role of carotid plaque detection/quantification in risk assessment.

• Smoking cessation management.

• Need to address INTERHEART trial, PLAC/LpPCA2 use in practice.

• Need Lp(a) to be addressed in patients seeking evaluation for possible premature CAD risk.

• Neil Stone from University of Wisconsin-Madison.

• More on nutrition and CVD.

• What exactly is the Mediterranean diet and can it really be reproduced here in the United States

with so many chemicals in our foods?

4. Comments:

• Excellent symposium. (9)

• Excellent speakers. (3)

• Excellent and relevant topics. (3)

• Good show. (2)

• Great. (2)

• Really enjoy ending earlier in the day. (2)

• Great educational program. (2)

• Very well organized and thought provoking.

• This conference was highly informative.

• Dr. Dayspring is an excellent and engaging presenter.

• Very well done.

• I really appreciate the conference room set-up with tables to make note taking easier.

• Food choices were healthy, thanks.

• I like the mental health balance.

• I like the practical, primary care focuses lectures.

• Continue with 20 minute lectures, but stay on time.

• Thanks for adding nutrition to this conference.

• Loved the view on the terrace.

• Please return to the Fontainebleau since it is half of the reason I attend.

• Excellent presentations and speakers who are clearly experts in the field. (2)

• Good conference, very informative and full of new information.

• Best seminar I have ever attended.

• I like the classroom style seating.

• Panels were fantastic.

• It was interesting to hear different perspectives on the newest guidelines.

• New information extremely helpful.

• Very well done.

• Superb venue, very friendly.

• I enjoyed the program.

• If using multiple screens, the presenters need to use the pointer in the computer so that everyone

can see what is being referred to.

• Post more signs in the building so we can find the conference.

• Far walk from the valet parking.

• Location is beautiful, but the drive is terrible.

• Fontainebleau is noisy and has poor service. It was worse than ever this year.

• Location is bad. Traffic and cost.

• Get off the beach.

• Hotel is good, but too far.

• I sensed that speakers were trying to rush through their presentations.

• Need more opportunity for questions and answers.

• The atrium of this hotel is extremely loud in the evening.

• Would be nice if we could check out of our room after the conference ends.

• Hotel is too expensive. (2)

• Did not enjoy all the extra costs associated with staying at the hotel. Would prefer a less expensive

option. (2)

CONTINUING MEDICAL EDUCATION DEPARTMENT Cardiovascular Disease Prevention

13th Annual International Symposium Thursday, February 19, 2015



FACULTY EVALUATION: 5- Excellent 4- Very Good 3- Good 2-Fair 1-Poor

Cardiovascular Disease Prevention 2015: Overview

Michael Ozner, M.D. 4.7

The Mediterranean Diet: The Optimal Diet for Cardiovascular Health

Vasanti Malik, Sc.D. 4.3

Sitting, Physical Activity and CVD Risk: Opposite Sides of the Same Coin?

Peter Katzmarzyk, Ph.D. 4.4

The Science of Mindfulness for Health and Well-being

Carl E. Fulwiler, M.D., Ph.D. 4.4

Egg and Dairy Consumption: Impact on CVD Risk


Saturated Fatty Acids and Risk of CHD: Modulation by Replacement Nutrients


Exercise and Cardiometabolic Health


Popular Weight Loss Diets: From Evidence to Practice


Reverse Cholesterol Transport: Is LDL More Important than HDL?

Thomas Dayspring, M.D. 4.6

LDL and the Benefits of Statin Therapy

Allan Sniderman, M.D.

4.7

Sterols: What the Practitioner Needs to Know


ApoB Versus Non-HDL Cholesterol as a Risk Marker and Target of Therapy – And the Winner Is…

Allan Sniderman, M.D. 4.7

Sleep Apnea: Advances in Diagnosis and Treatment to Lower CVD Risk

Timothy Grant, M.D.

4.7

OBJECTIVE EVALUATION: 5- Excellent 4- Very Good 3- Good 2-Fair 1-Poor

• Implement proper clinical guidelines related to primary and secondary prevention or disease

management to substantially reduce morbidity and mortality of cardiovascular events in the

current and future patient population. 4.5

• Explain the complexities of HDL mediated cholesterol transport. 4.3

• Employ a practical and sensitive way to raise the issue of weight with a patient or family and

effectively stimulate patients toward healthy lifestyle choices as a means to improve

cardiometabolic health. 4.4

• Discuss the cardiovascular health risks associated with sedentary behavior, and distinguish the

extent of increased health risks associated with sitting vs. physical inactivity. 4.6

• Explain the role of exercise in treating cardiometabolic disease among obese individuals. 4.5

• Recognize components of the optimal diet for cardiovascular health, and explain the scientific

evidence behind popular weight loss diets.

Examine the evidence for mindfulness-based interventions that promote health as part of an

approach to weight loss and weight loss maintenance.

4.5

• Discuss new perspectives and evidence on the CVD risks and benefits related to dietary factors. 4.4

Total Average 4.5

Was this symposium fair, balanced, and free of commercial bias?

Yes 121

No 0

No Answer 9

How many patients will you see in your practice next week that will likely be impacted by what you learned at this

symposium?

21 1-5 (16%) 26 6-10 (20%) 52 Over 10(40%) 18 Not Applicable (14%) 13 No Answer(10%)

What do you intend to do differently in the treatment of your patients as a result of what you learned at this symposium? What

new strategies will you apply in your practice of patient care?

• Use ApoB for diagnosis. (24)

• Spend more time and more detail discussing diet and exercise. (18)

• Focus more on mindfulness. (7)

• Be more suspicious of obstructive sleep apnea. (6)

• Recommend the Mediterranean diet. (6)

• Encourage healthy lifestyle choices. (4)


• Better statin management. (4)

• More sleep studies. (4)

• Test for sterols and absorption. (4)

• Use more Ezetimibe. (3)

• Encourage less sedentary lifestyle. (3)

• Discuss egg consumption. (2)

• Order PSG more often.

• Better differentiation of patients for proper treatment.

• Encourage blueberry consumption.

• Practice number evaluations.

• Increase use of Zetia.

• Better evidence-based teaching.

• Pay more attention to lipid disorders.

• Measure waist more frequently.

• Dietary interventions.

• Better knowledge of HDL.

• Increase meditation.

• Implement diet questionnaire.

• Enhance appreciation for a healthy diet and exercise.

• Talk to my patients about yogurt.

• Order labs more intelligently.

If you do not plan to implement any new strategies learned at this symposium, please list any barriers or obstacles that

might keep you from doing so.

• Time.

CONTINUING MEDICAL EDUCATION DEPARTMENT Cardiovascular Disease Prevention 13th Annual International Symposium

Thursday, February 19, 2015

Non-Physicians Attended: 212

Non-Physicians Responded: 110


Cardiovascular Disease Prevention 2015: Overview


The Mediterranean Diet: The Optimal Diet for Cardiovascular Health


Sitting, Physical Activity and CVD Risk: Opposite Sides of the Same Coin?


The Science of Mindfulness for Health and Well-being


Egg and Dairy Consumption: Impact on CVD Risk


Saturated Fatty Acids and Risk of CHD: Modulation by Replacement Nutrients


Exercise and Cardiometabolic Health


Popular Weight Loss Diets: From Evidence to Practice


Reverse Cholesterol Transport: Is LDL More Important than HDL?


LDL and the Benefits of Statin Therapy

Allan Sniderman, M.D.

4.6

Sterols: What the Practitioner Needs to Know


ApoB Versus Non-HDL Cholesterol as a Risk Marker and Target of Therapy – And the Winner Is…

Allan Sniderman, M.D. 4.7

Sleep Apnea: Advances in Diagnosis and Treatment to Lower CVD Risk

Timothy Grant, M.D.

4.9


• Implement proper clinical guidelines related to primary and secondary prevention or disease

management to substantially reduce morbidity and mortality of cardiovascular events in the

current and future patient population. 4.6


• Employ a practical and sensitive way to raise the issue of weight with a patient or family and

effectively stimulate patients toward healthy lifestyle choices as a means to improve

cardiometabolic health. 4.5

• Discuss the cardiovascular health risks associated with sedentary behavior, and distinguish the

extent of increased health risks associated with sitting vs. physical inactivity. 4.7

• Explain the role of exercise in treating cardiometabolic disease among obese individuals. 4.7

• Recognize components of the optimal diet for cardiovascular health, and explain the scientific

evidence behind popular weight loss diets.

Examine the evidence for mindfulness-based interventions that promote health as part of an

approach to weight loss and weight loss maintenance.

4.7

• Discuss new perspectives and evidence on the CVD risks and benefits related to dietary factors. 4.6

Total Average 4.6


Yes 106

No 0

No Answer 4


symposium?

10 0-5(9%) 14 6-10 (13%) 45 Over 10 (41%) 33 Not Applicable (30%) 8 No Answer (7%)



• Encourage exercise and proper diet. (15)

• ApoB testing. (12)

• Apply mindfulness. (7)

• Provide more diverse education and options on diet. (6)

• Increase sleep studies. (4)

• Prescribe Mediterranean diet instead of low fat diet. (4)

• Educate on cardiovascular disease (CVD). (3)

• More focus on low carb, moderate fat. (3)

• Share information. (3)

• Add stress management techniques. (2)

• Educate on weight loss. (2)

• Encourage yogurt intake. (2)

• Reduce amount of sedentary time.

• Revise views about LDL and cholesterol and how to fix.

• Add Zetia prior to a statin.

• Advise patients to exercise 150 minutes a week.

• Treat individually, not by group guidelines.

• Awareness, education, support.

• Read article on phlebotomy and lower cholesterol.

• Supplement diagnostic testing.

• Reconsider intense statin therapy and further testing for cholesterol.



• Patient non-compliance. (2)

• It is difficult for the older population.

• Financial constraints.

• Do not have follow-up with patients.

• Time.

CONTINUING MEDICAL EDUCATION DEPARTMENT Cardiovascular Disease Prevention 13th Annual International Symposium

Friday, February 20, 2015




The IMPROVE-IT Trial: Lessons Learned and Clinical Implications


The Obesity Epidemic: Practical Management Approaches

Goutham Rao, M.D. 4.6

The Role of Exercise in the Treatment and Prevention of Obesity


Adiposopathy ("sick fat"), Metabolic Disease and Ockham’s Razor

Harold Bays, M.D. 4.4

Mindfulness-based Interventions for Weight Loss


Low Sodium Intake: Cardiovascular Health Benefit or Risk?

Suzanne Oparil, M.D. 4.5

“Smoldering” Insulin Resistance with Impaired Fasting Glucose: How to Prevent Progression

to Diabetes and Lower CVD Risk

Harold Bays, M.D.

4.4

JNC 8 Blood Pressure Guidelines


CVD Prevention in Patients with Diabetes


Mobile Health Applications in Cardiovascular Disease Prevention

Theodore Feldman, M.D. 4.6

Diagnosis and Treatment of Resistant Hypertension


The Genomics of CVD Risk

Michael Davidson, M.D. 4.3

Are Triglycerides a Cardiovascular Risk Factor?

Christie Ballantyne, M.D. 4.4

The Link Between Liver Disease and Lipidology


Atherosclerosis Vaccine: Hope or Hype

Prediman K. Shah, M.D. 4.5


• Explore new perspectives and ongoing controversies about approaches to risk reduction

and treatment of atherosclerotic cardiovascular disease including the prospect of an

atherosclerosis vaccine.

4.6

• Identify and address genetic factors and comorbid conditions that are contributors to

metabolic disease and linked to CVD. 4.4

• List and describe the 5As of Obesity Management™ (5As) paradigm as an intervention to

maximize effectiveness of care, and address provider-identified barriers to obesity

management.

4.6

• Describe a framework of digital health and illustrate promising approaches to

cardiovascular disease prevention within this framework. 4.4

Total Average 4.5


• Seemed to favor bariatric surgery, despite no evidence.

• Too much talk about Zetia, not balanced.

Yes 110

No 2

No Answer 22


symposium?




• Counsel on obesity. (9)

• Resistant HTN. (6)

• Better approach to obese patients. (5)


• Consider Zetia as an addition to a statin. (4)

• Recommend health applications to encourage lifestyle changes. (4)

• Recommendations for sodium lowering. (3)

• Start using mindfulness on a more frequent basis. (2)

• Will add more information using the 5 A’s of obesity management and digital health. (2)

• New techniques in weight loss management. (2)

• Consider ApoB screening. (2)

• Treat hypertension (HTN) patients differently. (2)

• Better recognition and treatment of patients with primary biliary cirrhosis. (PBC)

• Start earlier with some medications.

• Better teaching.

• Lower dose statins.

• For patients over 60 blood pressure goal is 150/90.

• Start with a diuretic for initial HTN management.

• To convince patient that their weight loss will be both our tasks.

• Psycho-education on high blood pressure.

• Physical activity and nutrition.

• Improved approach to dietary management.

• Will study program online before changing.

• Ask patient self directed questions.

• Teach the patient to eat the right food.

• More specific exercise advice at visits.

• Thyroid diagnosis. Lighten up on sodium restrictions in most patients.



• Time. (4)

• Patient compliance. (2)

• Lack of reimbursement.


13th Annual International Symposium Friday, February 20, 2015

Non Physicians Attended: 212

Non Physicians Responded: 109


The IMPROVE-IT Trial: Lessons Learned and Clinical Implications


The Obesity Epidemic: Practical Management Approaches

Goutham Rao, M.D. 4.8

The Role of Exercise in the Treatment and Prevention of Obesity


Adiposopathy ("sick fat"), Metabolic Disease and Ockham’s Razor


Mindfulness-based Interventions for Weight Loss


Low Sodium Intake: Cardiovascular Health Benefit or Risk?


“Smoldering” Insulin Resistance with Impaired Fasting Glucose: How to Prevent Progression

to Diabetes and Lower CVD Risk

Harold Bays, M.D.

4.8

JNC 8 Blood Pressure Guidelines


CVD Prevention in Patients with Diabetes


Mobile Health Applications in Cardiovascular Disease Prevention

Theodore Feldman, M.D. 4.8

Diagnosis and Treatment of Resistant Hypertension


The Genomics of CVD Risk


Are Triglycerides a Cardiovascular Risk Factor?


The Link Between Liver Disease and Lipidology


Atherosclerosis Vaccine: Hope or Hype






4.7

• Identify and address genetic factors and comorbid conditions that are contributors to

metabolic disease and linked to CVD. 4.7

• List and describe the 5As of Obesity Management™ (5As) paradigm as an intervention to

maximize effectiveness of care, and address provider-identified barriers to obesity

management.

4.8

• Describe a framework of digital health and illustrate promising approaches to

cardiovascular disease prevention within this framework. 4.8

Total Average 4.7


Yes 93

No 0

No Answer 16


symposium?




• Teach patients about available mobile health applications. (8)

• Re-evaluate obesity assessment/discussion with patients. (5)

• Improve education for patients. (4)

• Incorporate mindfulness for weight management. (4)

• Promote lifestyle changes. (3)

• Emphasize multifactoral approach to treatment and prevention. (3)

• Sodium recommendations. (2)

• Better management of resistant hypertension. (2)

• Try chlorthalidone. (2)

• JNC8 guidelines. (2)

• Behavioral approaches. (2)

• Use of VIT for NASH. (2)

• The 5 A’s of obesity management.

• More on-line engagement.

• Educate staff.

• Implement new blood pressure (BP) goals for newly onset hypertension patients.

• Incorporate mindful eating strategies into my practice.

• Look closer at BP management.

• Explore new perspectives and ongoing controversies about approaches education and treatment of CVD.

• Study more about genomics and personalized therapies.

• Add sleep study.

• Add Aldosterone antagonist.

• Engage physicians in a dialogue about the rationale behind different treatment choices.

• Plant sterol assessment.

• Improve my interaction with patients.

• To reconsider triglycerides as risk factors for CVD and to reinforce treatment.



• None listed.


13th Annual International Symposium Saturday, February 21, 2015




Cardiovascular Disease Prevention in HIV Patients

Wendy Post, M.D. 4.5

Familial Hypercholesterolemia

Anne Goldberg, M.D. 4.7

CVD-related Mutations: Should They be Part of Our Office Work-up?


2013 ACC/AHA Cholesterol Guidelines


National Lipid Association Recommendations

Carl Orringer, M.D. 4.7

International Atherosclerosis Society Recommendations


The Great Statin Debate in Primary Prevention

Moderator: Michael Ozner, M.D. 4.7

New Cholesterol Guidelines: Carte Blanche for Statin Overuse

Rita Redberg, M.D. 4.5

Overestimation with the 2013 ACC/AHA CVD Risk Calculator: Is CRP the Best Guide for Statin

Treatment?

Paul Ridker, M.D.

4.7

Selective Use of Statins: Can We Appropriately Allocate Resources Using CAC Testing?

Khurram Nasir, M.D. 4.6

Keynote Address: The Future of Preventive Cardiology


Integrating Imaging and Biomarkers for Optimal CVD Risk Assessment and Management

Arthur Agatston, M.D. 4.6

Novel Approach to Biomarker Utilization: Conception to Clinical Practice


Menopausal Hormone Therapy: Do the Cardiovascular Warnings Preclude its Use?


CVD Prevention in Women


Inflammation and Atherosclerosis

Paul Ridker, M.D. 4.7


• Assess methodologies for establishing risk profiles, and identify and address known or potential

CVD risk factors. 4.7

• Apply latest guidelines for measurement, assessment and treatment related to hypertension,

cholesterol, dyslipidemia, statin use, hormone therapy and testosterone supplements and obesity. 4.6

• Explore new perspectives and ongoing controversies about approaches to risk reduction and

treatment of atherosclerotic cardiovascular disease including the prospect of an atherosclerosis

vaccine. 4.6

• Recognize novel approaches to biomarker utilization for risk assessment, management and

evaluation of efficacy of therapy. 4.5

• Discuss new perspectives on the derivation of benefit when LDL is lowered. 4.4


• Examine recommended approaches to statin treatment comparing targets of therapy and

standard dosing, and discuss concerns about statin overuse. 4.6

• Recognize differences in CVD clinical presentations and outcomes between men and women,

and implement women-specific clinical recommendations for the prevention of CVD. 4.6

• Interpret the current guidelines about menopausal hormone therapy including extended use. 4.7

Total Average 4.6


Yes 119

No 1

No Answer 10


symposium?




• Increase CAC scoring testing. (11)

• More use of non HDL cholesterol levels. (6)

• Risk stratification. (5)

• More informed discussion involving initiation of statin therapy. (4)

• +

• Use Reynolds Risk Score more frequently. (3)

• Observe for familial hypercholesterolemia (FH). (2)

• Assess risk of CTA events on more individual basis. (2)

• More frequent CRP measurement. (2)

• Menopausal strategies. (2)

• Look at non-calcified plaque.

• Increase screening in selected groups.

• Biomarkers and target highly on residual risk.

• Estrogen use.

• Look at CTA differently.

• More patient education.

• Lifestyle modification.

• Statin/target control.

• More evidence-bases practice.

• Discuss issues of cholesterol management.

• Treatment of CVD risk in women.

• ApoB targets.

• May consider adding Zetia again.

• Use drug treatment in conjunction with lifestyle changes.

• Consider using global risk scores for prediction of treatment of diabetes.

• Take the time to teach about eating the proper food.

• Research guidelines more closely.

• Increase screening for diabetes and stroke in addition to other risk factors.



• Cost.

• Time to discuss.

• Time.

• Resources.


13th Annual International Symposium Saturday, February 21, 2015




Cardiovascular Disease Prevention in HIV Patients

Wendy Post, M.D. 4.8

Familial Hypercholesterolemia


CVD-related Mutations: Should They be Part of Our Office Work-up?


2013 ACC/AHA Cholesterol Guidelines


National Lipid Association Recommendations


International Atherosclerosis Society Recommendations


The Great Statin Debate in Primary Prevention

Moderator: Michael Ozner, M.D. 4.8

New Cholesterol Guidelines: Carte Blanche for Statin Overuse


Overestimation with the 2013 ACC/AHA CVD Risk Calculator: Is CRP the Best Guide for Statin

Treatment?

Paul Ridker, M.D.

4.8

Selective Use of Statins: Can We Appropriately Allocate Resources Using CAC Testing?


Keynote Address: The Future of Preventive Cardiology


Integrating Imaging and Biomarkers for Optimal CVD Risk Assessment and Management

Arthur Agatston, M.D. 4.7

Novel Approach to Biomarker Utilization: Conception to Clinical Practice


Menopausal Hormone Therapy: Do the Cardiovascular Warnings Preclude its Use?


CVD Prevention in Women


Inflammation and Atherosclerosis

Paul Ridker, M.D. 4.8


• Assess methodologies for establishing risk profiles, and identify and address known or

potential CVD risk factors. 4.8

• Apply latest guidelines for measurement, assessment and treatment related to

hypertension, cholesterol, dyslipidemia, statin use, hormone therapy and testosterone

supplements and obesity.

4.7




4.8

• Recognize novel approaches to biomarker utilization for risk assessment, management

and evaluation of efficacy of therapy. 4.6

• Discuss new perspectives on the derivation of benefit when LDL is lowered. 4.7


• Examine recommended approaches to statin treatment comparing targets of therapy

and standard dosing, and discuss concerns about statin overuse. 4.8

• Recognize differences in CVD clinical presentations and outcomes between men and

women, and implement women-specific clinical recommendations for the prevention of

CVD.

4.7

• Interpret the current guidelines about menopausal hormone therapy including extended

use. 4.8

Total Average 4.7


Yes 96

No 0

No Answer 3


symposium?




• Focus on healthy lifestyle. (10)

• Look into family’s cholesterol history. (6)

• Check calcium scores more often. (3)

• Will not give hormone therapy to women over 70. (2)

• Re-assess use of high statin dose in the frail, elderly patient. (2)

• More aggressive treatment of LDL, especially in diabetics.

• Share with my colleagues.

• If CAC score is 0, no statin therapy.

• Take a better history.

• Focus on anti-inflammatory advantage.

• I will apply the latest guidelines for measurement, assessment and treatment related to hypertension, cholesterol,

dyslipidemia, statin use, hormone therapy and testosterone supplements and obesity.

• Can share more evidence with those patients that desire to be part of the decision making process.

• Improved provider education.

• Assess women patients for risk of CVD.

• More open to MRT use in women with vasomotor symptoms.

• More tools for patients.

• Consider the lowest dose and shortest amount of time for hormone replacement therapy.



• Cost. (2)

• Medicare.


13th Annual International Symposium Sunday, February 22, 2015




Controversies in Cardiovascular Prevention: Answers to Key Questions Your Patients are

Asking

Michael Blaha, M.D.

4.6

Statin Safety: What Every Health Care Provider Needs to Know


Urinary11-Dehydrothromboxane B2 to Evaluate Atherothrombotic Risk and Aspirin Resistance

Peter A. McCullough, M.D. 4.7

The Prevention and Management of Peripheral Vascular Disease

Ian Del Conde, M.D. 4.7

Erectile Dysfunction: An Early Sign of Cardiovascular Disease

Michael Blaha, M.D. 4.8

Low T and the Heart: Testosterone Therapy and CVD Risk

Kevin Billups, M.D. 4.8

Stroke: From Prevention to Intervention

Italo Linfante, M.D. 4.4

CVD Prevention in Patients with Chronic Kidney Disease


Corporate Wellness: Novel Approaches to Reduce CVD Risk


Late Breaking News for the Treatment of Acute Stroke






4.7

• Assess the impact of CVD prevention and management therapies on the prevention and

severity of stroke. 4.6

• Review results of an employer-supported corporate wellness program. 4.7

Total Average 4.7


Yes 85

No 0

No Answer 14


symposium?




• Check Urinary 11-Dehydrothromboxane B2 (11dhTxB2) for aspirin (ASA) resistance. (10)

• Consider alternate antiplatelet therapies in peripheral vascular disease (PAD). (6)

• Screen men with erectile dysfunction for cardiovascular disease. (5)

• More aggressive treatment for patients with comorbidities. (3)

• CVD prevention with lifestyle changes and mindfulness. (2)

• Reconsider my practice regarding low testosterone patients. (2)

• More organized approach to managing patients who claim side effects from statins including vitamin D levels.

• Discussion of preventive strategies.

• More risk factor evaluation and labs.

• Be more proactive.

• Be more perceptive to question from patients regarding diet, vitamins and exercise.

• Share more detailed information especially for men’s and women’s health.

• Use Ezetimibe in combination with simvistatin for chronic renal disease.

• Encourage diet/ moderate coffee/ no smoking or E-cigarettes.

• Teach to eat the right food.

• Increase carotid screening.



• Cost of medication.

• Lack of insurance coverage.

• Cost.


13th Annual International Symposium Sunday, February 22, 2015




Controversies in Cardiovascular Prevention: Answers to Key Questions Your Patients are

Asking

Michael Blaha, M.D.

4.8

Statin Safety: What Every Health Care Provider Needs to Know


Urinary11-Dehydrothromboxane B2 to Evaluate Atherothrombotic Risk and Aspirin Resistance


The Prevention and Management of Peripheral Vascular Disease

Ian Del Conde, M.D. 4.7

Erectile Dysfunction: An Early Sign of Cardiovascular Disease

Michael Blaha, M.D. 4.9

Low T and the Heart: Testosterone Therapy and CVD Risk

Kevin Billups, M.D. 5.0

Stroke: From Prevention to Intervention


CVD Prevention in Patients with Chronic Kidney Disease


Corporate Wellness: Novel Approaches to Reduce CVD Risk


Late Breaking News for the Treatment of Acute Stroke






4.7

• Assess the impact of CVD prevention and management therapies on the prevention and

severity of stroke. 4.7

• Review results of an employer-supported corporate wellness program. 4.6

Total Average 4.7


Yes 52

No 0

No Answer 10


symposium?




• Will discuss new findings with colleagues. (2)

• Provide better advice to patients questioning medication and supplements for CVD prevention. (2)

• Discuss stopping E-cigarette use.

• Give patients important information.

• More screening for possible cardiovascular disease prevention (CVD).

• Educate patients and families.

• Teach pharmacists and residents about new treatments for acute ischemic stroke.

• Screen for low testosterone levels.

• Ask physicians to order more baseline checks and more intensive follow-up with patients on lifestyle therapies.

• To better address patient’s concerns about treatment with statins.

• Clinical assessment involving phosphorous and magnesium levels prior to CEA surgeries.

• Refer more men to have discussion with their private medical doctor about low testosterone.

• I will implement this information in assessment of patients.

• Be more lenient with the use of testosterone treatment in patients with cardiac disease or risk.

• Check Urinary 11-Dehydrothromboxane B2 (11dhTxB2) for aspirin (ASA) resistance.

• Lack of understanding or inability of patients to take responsibility for their disease process.

• Development of adherence programs for exercise, diet and lifestyle changes.

• I will assess methodologies for establishing risk profiles and I’ll identify and address known potential CVD risk factors.



• None listed.

Seventh Annual Mental & Behavioral Health Symposium February 28, 2015

Physicians and Psychologists Attended: 115

Physicians and Psychologists Responded: 114

FACULTY EVALUATION: Please rate the effectiveness of the presenters in meeting their educational objectives:

5- Excellent 4- Very Good 3- Good 2-Fair 1-Poor Beyond Resilience and Post-traumatic Stress Disorder: Flexibility and Heterogeneity Following

Potential Trauma

George Bonanno, Ph.D. 4.9

• Compare post-traumatic stress disorder to a broader theoretical approach that takes into

account the natural heterogeneity of trauma reactions over time. 4.8

• Apply knowledge of divergent response patterns to clinical practice. 4.7

• Identify different types of predictors of trauma outcome and assess their role in healthy

adjustment to aversive life events. 4.8

• Recognize prototypical patterns or trajectories of trauma reaction that include chronic

dysfunction, but also delayed reactions, recovery and psychological resilience. 4.8

Trauma and Resilience in Children and Adolescence

Annette M. La Greca, Ph.D., ABPP 4.8

• Identify risk factors that contribute to post-disaster posttraumatic stress reactions in children. 4.7

• Identify aspects of the post-disaster recovery period that either maintain or help to mitigate

children’s distress. 4.7

• Identify important areas to include in an assessment of children post-disaster. 4.7

• Describe intervention strategies used to enhance resilience factors and reduce risk factors in

youth post-disaster. 4.7

Addiction: Resilience and Family

John Eustace, M.D. 4.0

• Examine resilience factors among those with drug and/or alcohol abuse problems. 4.0

• Recognize and address factors that contribute to relapse. 4.0

• Develop strategies and interventions to enhance resilience and coping in the face of stress and

prevent the onset of addiction problems or relapse. 4.0

Total Average 4.5

Was this Workshop fair, balanced, and free of commercial bias?

• Dr. Bonanno focused too much on his own work and talking about himself, than on

discussing the topic.

• The 2nd lecture was promoting global warming politics.

Yes 107

No 2

No Answer 5

Scoring Key: 5 – Great Deal 4 – A Good Deal 3 - Neutral 2 – A little 1 – Very Little

How much did you learn as a result of this continuing education program? 4.7


symposium?

60 0-10(53%) 21 10-15 (18%) 17 15-20(15%) 3 20-25 (3%) 4 Over 25 (4%) 9 No Answer(8%)

What do you intend to do differently as a result of what you learned at this symposium?

What new strategies will you apply in your practice of patient care?

• Better able to identify risk factors/symptoms of PTSD. (10)

• Develop strategies to increase resiliency and flexibility. (9)

• Pursue additional trauma training in websites that were recommended. (6)

• Implement information learned about stress model as well as resilience factors. (4)

• Increase information on optimism resiliency. (4)

• Intervention immediately following a traumatic event. (3)

• I will change how I educate patients about PTSD. (2)

• Provide education about resilience. (2)

• Resources for cognitive based training (CBT). (2)

• Include in assessment risk factors to adjustment in appropriate areas. (2)

• Include new concepts and strategies learned today, such as helping patients to realize trajectories of trauma

reactions. (2)

• Provide more psycho-education about different responses and what a person may be able to expect following

trauma. (2)

• Long term approach.

• Introduction of brief assessments for trauma to help with intervention.

• Importance of allowing for innate coping skills to kick in.

• Assess and explain potential recovery and understanding of the different statistical approaches to interpretive

data.

• Spirituality and resilience.

• Apply response pattern in individuals to practice.

• Look for psychopathological symptoms in my patients.

• Statistical analysis in current research.

• Teach mindfulness and relaxation techniques in high risk PTSD patients.

• Realize I have more awareness of statistics.

• Be more aware of the patients’ social history.

• PTSD treatment strategies.

• Orientation and guide to specialist when needed.

• Use ideas in therapy of promoting resilience, flexibility, greater adaptability and other techniques that aid recovery

and many other suggestions.

• Identify resilient patients and minimize interventions.

• Will be better able to discuss data behind recommendations to patients.

• Focus on decreasing negative factors to resilience in substance abuse.

• Access PTSD websites and inform patients of these resources.

• More consideration for screening tool implantation.

• Resilience in cancer patients and their families, especially pediatrics.

• Address resilience in terms of social support.

• Practice mindfulness.

• Development of flexibility skills.

• Help patients increase chances of change and identify occasions for change.

• Integrate instillation of hope technique based on high resilience rates learned today.

• Correctional medicine.

• Understanding addiction.

• Apply to Academia.

• Reinforced my views on resilience and recovery.

• Ask about potential traumatic events more often.

• Inquire about coping skills to increase understanding of resilience.

• Delve deeper into life experiences during clinical interviews.

• Accept it and redirect the person to something that works.

• Better guidelines with elite athletes in dangers and resilience in alcohol.

• Latency trajectory modeling was of great interest.



• HMO limitations.

• Work in a federal prison.

• Patients individual differences.

Suggested topics and/or speakers you would like for future symposiums related to Ob/Gyn.

• Explore new areas like positive psychology, alternative medicine and mindfulness. (5)

• Updates in psychopharmacology. (3)

• Would like to have seen more information on interventions of evidence based treatments for PTSD with children and

adolescents. (2)

• Neuropsychological component and its influence in presentation of symptoms and recovery course. (2)

• Bipolar disorder. (2)

• Borderline personality disorder. (2)

• Autism. (2)

• Forensic psychology topics. (2)

• Dr. La Greca. (2)

• Helping the geriatric population.

• Suicide with police and military.

• Use of hypnotherapy.

• Emotion regulation and mindfulness for PTSD.

• Address obvious problems and ethical issues when therapists have been impacted by trauma.

• Schizophrenia.

• More on addiction treatment.

• DSM-5 Discussion/review.

• Spirituality and mental health.

• ADHD.

• Adolescent self destructive behaviors.

• Treatment of OCD and phobias.

• Pain management.

• More on addiction medicine.

• Neuropsychological disorders.

• Childhood sociopathy.

• Clinical hypnosis.

• The law and psychology issues.

• Stress management.

• Coping with illness.

• Couples treatment.

• Executive functions of the brain.

• Resilience with chronic medical issues.

• Neurobiology of attachment and how it translates to psychopathology and critical treatment.

• Alcohol and trauma or sexual violence or domestic violence.

• Dementia versus mild cognitive impairment (MCI).

• Caregiver burden.

• Mental status exam.

• More workshops on applications.

• Latest data on relationships among mind, brain and consciousness.

• Mental health in the emergency room.

• Accelerated resolution therapy for PTSD.

• Psychotherapy versus pharmacological intervention.

• Burnout due to professional responsibilities, insurance, life, etc.

Comments

• Excellent program. (6)

• Good selection of presenters. (4)

• Very good practical information. (3)

• The AA member was fabulous. (2)

• Dr. Bonanno was great, engaging and maintained the audience’s attention. (2)

• Thank you for this excellent symposium.

• Well done.

• Excellent, dynamic presentations.

• Very interesting symposium.

• One of the best symposiums ever.

• Speakers were knowledgeable and not boring.

• Good presentations with evidence base.

• First presenter was excellent.

• Always very informative and well planned.

• Congratulations to Andy and Terry.

• Very good topics.

• This is a great learning opportunity.

• Thank you for offering free CEU’s; they are also very good presentations.

• Presenters were very knowledgeable and provide updated information with a sense of humor.

• Unfortunately Dr. Eustace was cut short. His presentation should have been 2 hours, not 1.

• The extra room was great. Jose was very helpful, but we could not see the presenter on the screen.

• The 1st speaker was excellent; the following 2 were just filler.

• Thank you for contributing to the field.

• Dr. Eustace’s presentation and that of the alcoholics were very interesting, but did not address the topic as

expected.

• Application to practice most helpful.

• I am impressed by the information obtained from using the trajectory models.

• The room was far too small for this large audience.

• Need better trash processing.

• Symposium geared toward assessment and statistics with a minimum focus on strategies for adults.

• Buffet tables were poorly placed and very crowded.

• Should have presentation slide handouts or resources for same online.

• Presentation links were not working before the conference.

• Would have been helpful if all the speakers were familiar with the technology used ahead of time.

• No microphones in extra rooms for us to ask questions.

• A better microphone system for the future.

• Prior practice of presentation by Dr. Eustace would have improved performance. (2)

• Could not see the speaker on the screen in the extra room. (2)

• Sound problems. (3)

• A lot of technical difficulties. (4)

How did you hear about this Symposium?

(46%) Email (52)

(36%) Postcard (41)

(26%) Mail (30)

(10%) Internet (11)

• Google (2)

• Baptist Health (5)

(3%) Poster (3)

(7%) Other (8)

• Colleague (3)

• Word of mouth

• Invitation.

• Friend

Yes No No Answer


Would you attend this symposium again next year? (114) 100% (0) 0% (0) 0%

Would you recommend this symposium to a colleague? (111) 97% (0) 0% (3) 3%

Participation in this learning activity has:

Improved my competence (ability to perform) 107 Yes 3 No 4 No Answer

Enhanced my performance 98 Yes 6 No 10 No Answer

Insured that my patients will have improved outcomes 94 Yes 9 No 11 No Answer

Seventh Annual Mental & Behavioral Health Symposium February 28, 2015

Non-Physician Attended: 97

Non-Physician Responded: 76

FACULTY EVALUATION: Please rate the effectiveness of the presenters in meeting their educational objectives:

5- Excellent 4- Very Good 3- Good 2-Fair 1-Poor Beyond Resilience and Post-traumatic Stress Disorder: Flexibility and Heterogeneity Following

Potential Trauma

George Bonanno, Ph.D. 4.9

• Compare post-traumatic stress disorder to a broader theoretical approach that takes into

account the natural heterogeneity of trauma reactions over time. 4.8

• Apply knowledge of divergent response patterns to clinical practice. 4.7

• Identify different types of predictors of trauma outcome and assess their role in healthy

adjustment to aversive life events. 4.8

• Recognize prototypical patterns or trajectories of trauma reaction that include chronic

dysfunction, but also delayed reactions, recovery and psychological resilience. 4.7

Trauma and Resilience in Children and Adolescence

Annette M. La Greca, Ph.D., ABPP 4.8

• Identify risk factors that contribute to post-disaster posttraumatic stress reactions in children. 4.8

• Identify aspects of the post-disaster recovery period that either maintain or help to mitigate

children’s distress. 4.8

• Identify important areas to include in an assessment of children post-disaster. 4.7

• Describe intervention strategies used to enhance resilience factors and reduce risk factors in

youth post-disaster. 4.7

Addiction: Resilience and Family

John Eustace, M.D. 4.4

• Examine resilience factors among those with drug and/or alcohol abuse problems. 4.3

• Recognize and address factors that contribute to relapse. 4.3

• Develop strategies and interventions to enhance resilience and coping in the face of stress and

prevent the onset of addiction problems or relapse. 4.3

Total Average 4.6

Was this Workshop fair, balanced, and free of commercial bias?

Yes 72

No 0

No Answer 4

Scoring Key: 5 – Great Deal 4 – A Good Deal 3 - Neutral 2 – A little 1 – Very Little

How much did you learn as a result of this continuing education program? 4.7


symposium?

36 0-10(47%) 11 10-15 (14%) 6 15-20(8%) 5 20-25 (7%) 9 Over 25 (12%) 9 No Answer(12%)

What do you intend to do differently as a result of what you learned at this symposium?

What new strategies will you apply in your practice of patient care?

• Intervention strategies to enhance resilience factors. (6)

• Will evaluate/assess patients more carefully. (5)

• Focus on strengths to increase coping skills and resiliency. (4)

• Differentiate between various states of traumatic exposure and response to different client’s needs and

recommend appropriate treatments. (3)

• Reinforced what I am doing. (2)

• I would like to help and understand the feelings of my patients.

• Teach patients mindfulness skills.

• Will encourage flexibility.

• View each individual as unique. No adaptive or maladaptive coping.

• I will look at kids based on when PTSD started or event happened in the recovery process.

• I will be sure to thoroughly consider other, similar disorders when PTSD is evident, while assessing children.

• Use visual explanation of resiliency and adaptability.

• Be more aware of life stressors in patient’s lives.

• Will develop workshops to promote resiliency that is focused on populations with probability of chronicity.

• Aware that resiliency doesn’t occur overnight.

• Different aspects of resiliency.

• Understand that not all patients are resilient.

• Listen and understand.

• Pay close attention to resiliency and contributing factors.

• Take into account the effects of trauma and the resilience factors in the treatment of children and adolescents

form divorced parents.

• Ask a lot of open-ended questions.

• Mostly recognition.

• More aware of symptoms of PTSD and how to deal with it.

• I’ll further investigate some of the websites suggested.

• Continue to use mindfulness training with patients.

• Give more credit to a child’s ability to be resilient and recover from trauma.

• Spend more time mentoring.

• Increase coping skills.

• Use parents less as a reliable source for children with PTSD.

• Early detection.

• Acceptance and understanding of all patients.

• Recognize that patients with late recovery are at greater risk for chronic PTSD.

• Be more aware of risk of myocardial infarction with cardiac rehab patients with onset of depression.

• Continuation of building resilience as research in the area improves particularly as it relates to first responders and

disaster preparedness.



• Funding.

Suggested topics and/or speakers you would like for future symposiums related to Ob/Gyn

• Homeless and mental health addiction issued. (2)

• Resiliency and mindfulness/spirituality. (2)

• More emphasis on treatment. (2)

• Infant mental health issues. (2)

• Trauma focused cognitive behavior therapy (CBT). (2)

• Managing chronic mental health/substance use issues in a practice.

• Positive psychology applications to mental health treatment.

• Topics related to children and families such as trauma, attachment, abuse and neglect and infant mental health.

• Treatment implications.

• ADHD and substance abuse and other mental health issues.

• Psychological assessment for master level clinicians.

• Resiliency versus beliefs.

• Resiliency versus genetics.

• DSM-V.

• Association between mental health positive health symptoms versus negative.

• More on PTSD treatments.

• Repeat topic.

• Autism.

• Motivational interviewing.

• PTSD and resilience in children when a parent dies suddenly.

• How to help an adult child after sudden death of a parent.

Comments

• Excellent. (2)

• Great speakers. (2)

• Enjoyed the personal stories of addiction. (2)

• Jose, on staff, is great.

• Excellent speakers.

• Very interesting topics.

• Good resources were provided.

• Dr. Bonanno was a dynamic and engaging speaker.

• Wonderful.

• Appreciate this opportunity.

• Thanks a million.

• Truly one of the seminars I look forward to annually.

• Kudos to finding premier faulty to present current topics.

• Dr. Eustace was the heart and soul of the symposium.

• Extremely educational and productive.

• I really enjoy these symposiums. You provide high quality presentations and interesting topics.

• Great symposium and I can’t wait till next year.

• The overflow room was a good resiliency challenge.

• I wish Dr. Eustace had a longer presentation time.

• Most enjoyable, yet the hour chosen was most unfortunate.

• We were unable to view the speakers in the 2nd half.

• Classroom 5 was not conducive to learning and we couldn’t answer questions.

• For the overflow room instead of using a split screen, would rather a full screen of slides.

• Final presenter had issues with audio visual and slowed down the symposium. (2)

How did you hear about this Symposium?

(58%) Email (44)

(20%) Postcard (15)

(13%) Mail (10)

(9%) Internet (7)

• Baptist Health (4)

(16%) Other (12)

• Friend (3)

• Colleague (2)

• Baptist CME

• Email form work

Yes No No Answer


Would you attend this symposium again next year? (73) 96% (1) 1% (2) 3%

Would you recommend this symposium to a colleague? (73) 96% (0) 0% (3) 4%

Participation in this learning activity has:

Improved my competence (ability to perform) 71 Yes 1 No 4 No Answer

Enhanced my performance 65 Yes 5 No 6 No Answer

Insured that my patients will have improved outcomes 63 Yes 5 No 8 No Answer

CONTINUING MEDICAL EDUCATION EVALUATION SUMMARY

Conference Title: Cardiovascular Conference Series: Advances in Antithrombotic Therapy: Update on NOACs Conference Director: Marcus St. John, M.D. Date: Thursday, March 5, 2015 Time: 12 noon – 1:00 p.m. Locations: Baptist Hospital, 5MCVI, Live Webcast, Videoconference to Homestead Hospital, Mango Room, South Miami Hospital, MCVI Conference Room and West Kendall Baptist Hospital, Classrooms 4 & 5

Scoring Key: 5 - Strongly Agree 4 - Agree 3 - Neutral 2 - Disagree 1 - Strongly Disagree N/A- Not applicable for my practice

1. As a result of attending this conference, to what extent do you agree that you will be better able to:

• Analyze clinical studies of non-vitamin K antagonist oral anticoagulants (NOACs) and their impact on prevention and treatment of venous Thromboembolism (VTE).

4.8

• Implement strategies for the proper management and reversal of NOACs. 4.8

Scoring Key: 5 - Excellent 4 - Very Good 3 - Good 2 - Fair 1 – Poor N/A- Not applicable

2. Effectiveness of learning aids used (audio-visual, etc.) if applicable. 4.9

3. Conference content. 4.9

4. Effectiveness of the speaker:

• Alexander G.G. Turpie, M.D., FRCP, FACP, FACC, FRCPC 5.0

Total Average: 4.9

5. Was this conference fair, balanced and without commercial bias? Yes 7 No 0 No response 8

How many patients will you see in your practice next week that will likely be impacted by what you learned at this activity?

Number of Patients: 1-5 6-10 Over 10 No Answer Not applicable to my practice

Respondents: 2 1 0 12 0

Percent (rounded): 13% 7% 0% 80% 0%

What do you intend to do differently in the treatment of your patients as a result of what you learned at this conference? What new strategies will you apply in your practice of patient care?

• The concern or burden of preventable bleeding. • Discuss advantages and cost of NOAC’s versus Warfarin.

If you do not plan to implement any new strategies learned at this conference, please list any barriers or obstacles that might keep you from doing so:

• None listed. List topics related to this lecture that you want to learn more about:

• Any updates in one year. Comments:

• Good presentation. (2) • Excellent, consistent speaker.

Baptist Hospital -Live Attendance: 44 Physicians: 11 BHSF Employees: 30 Other: 3

Total Attendance: 57 Physicians: 15 BHSF Employees: 39 Other: 3

South Miami Hospital -VC Attendance: 5 Physicians: 0 BHSF Employees: 5 Other: 0

West Kendall Hospital -VC Attendance: 2 Physicians: 0 BHSF Employees: 2 Other: 0

Homestead Hospital -VC Attendance: 1 Physicians: 1 BHSF Employees: 0 Other: 0

Webcast Attendance: 5 Physicians: 3 BHSF Employees: 2 Other: 0


Conference Title: An Overview of the Art of Intentional Communication The Role of the Physician in The Patient Experience Date: Tuesday, March 10, 2015 Time: 7:30 – 8:00 a.m.. Location: West Kendall Baptist Hospital, Imaging Conference Room



• Appreciate the importance of delivering culturally and linguistically appropriate medical care. 4.8

• Address key areas of health disparities significantly affecting outcomes and readmission rates in minorities and foreign-born populations.

4.8

• Explain the legal ramifications of transculturally appropriate medical care. 4.8

• Discuss the resources available for effective communication when negotiating treatment – Limited English Proficiency interpreters, Triadic Interview and Cultural Competency Pathway.

5.0

• Effectively communicate for a better patient experience with specific tools – HACHPS, AIDET for physicians, LEARN and BATHE models.

4.9




4. Effectiveness of the speakers:

• Ian Nisonson, M.D. 4.9

Total Average: 4.9



• Communicate better with patients. • Use interpreter more. • Better patient care.


• None listed. List topics related to this lecture that you want to learn more about:

• None listed. Comments:

• Excellent presentation.

Attendance: 10 Physicians: 7 BHSF Employees: 3 Other: 0


Conference Title: Pediatric Emergency Conference: Delayed Diagnosis in Pediatric Acute Care- Avoid Legal Issues Conference Director: Jennifer P. Cheney, M.D. Date: Tuesday, March 10, 2015 Time: 6:00 – 7:30 p.m. Location: Baptist Hospital, Auditorium and videoconference to Homestead Hospital, Board Room



• Discuss common diagnoses that lead to malpractice suits in pediatric acute care and emergency medicine.

5.0

• Identify prominent factors contributing to diagnostic errors by examining previous medical legal cases in pediatrics.

5.0

• Implement strategies in emergency and acute pediatric care to reduce most-frequent diagnostic errors and process breakdowns.

5.0





• Steven M. Selbst, M.D. 5.0

Total Average: 5.0





Percent (rounded): 10% 5% 50% 30% 5%


• Improve communication. (6) • Document better in the chart. (7) • Chart times. (4) • Treat and consult with specialists. • Early diagnosis and referral. • More diligent in rendering care. • Have patient/family repeat back the instructions. • Diminish interruptions when evaluating patient.


• None listed.

List topics related to this lecture that you want to learn more about:

• ADHD. • Nutrition of the premature baby after discharge.

Comments:

• Outstanding talk and speaker. (2)

Total Attendance: Physicians: BHSF Employees: Other:

Homestead Hospital -VC Attendance: Physicians: 0 BHSF Employees: Other: 0

Doctors Hospital -VC Attendance: Physicians: BHSF Employees: Other:

Baptist Hospital -Live Attendance: 40 Physicians: 35 Psychologists: 2 BHSF Employees: 2 Other: 3

Total Attendance: 46 Physicians: 40 Psychologists: 2 BHSF Employees: 3 Other: 3

Homestead Hospital -VC Attendance: 6 Physicians: 5 BHSF Employees: 1 Other: 0


Conference Title: Ob/Gyn Conference Series: Infectious Diseases Conference Coordinator: Rene Paez, M.D. Date: Thursday, March 12, 2015 Time: 6:00 – 7:00 p.m. Location: South Miami Hospital, Classroom E & F



• Identify and manage infectious diseases commonly seen by obstetricians and gynecologists, including urinary tract infections, HIV, tuberculosis, endometriosis, chorioamnionitis and mastitis.

5.0

• Implement current vaccine recommendations. 5.0





• Jorge Murillo, M.D., FACP, FIDSA 5.0

Total Average: 5.0





Percent (rounded): 36% 14% 7% 29% 14%


• Emphasize vaccinations. • Different treatments.


• Rarely see pregnant patients. List topics related to this lecture that you want to learn more about:

• None listed. Comments:

• Great presentation.

Attendance: 30 Physicians: 14 BHSF Employees: 12 Other: 4

March 2015 Evaluation Summaries - Baptist Health South Florida · CME Conference Evaluation Summaries March 2015 FINAL SCORE 2/19 13th Annual International Cardiovascular Disease

Documents